GlassScriptPhysician profile
Carla N Hunter
NPI 1306813738
$338.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $61.81 · 2021: $29.57 · 2022: $36.20 · 2024: $17.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $56.71 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $48.42 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.20 | 2022 | |
| Glaxosmithkline, LLC. | $30.82 | 2019 | |
| Sobi, INC | $17.88 | 2019 | |
| Organogenesis INC. | $17.69 | 2024 | |
| Genentech USA, INC. | $17.64 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.13 | 2019 | |
| Kaleo, INC. | $16.90 | 2021 | |
| Tris Pharma INC | $15.85 | 2019 | |
| Neos Therapeutics, LP | $15.50 | 2019 | |
| Pfizer INC. | $13.24 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.15 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $11.75 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.